FdaApplication
ANDA 206803
Identifiers
- fda_app_no: ANDA206803
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2019-04-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SELEGILINE HYDROCHLORIDE | SELEGILINE HYDROCHLORIDE | 5MG | CAPSULE;ORAL |
1 product